These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 33334672)

  • 1. Comparison of Long Term Outcomes After Endovascular Treatment Versus Bypass Surgery in Chronic Limb Threatening Ischaemia Patients with Long Femoropopliteal Lesions.
    Zlatanovic P; Mahmoud AA; Cinara I; Cvetic V; Lukic B; Davidovic L
    Eur J Vasc Endovasc Surg; 2021 Feb; 61(2):258-269. PubMed ID: 33334672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Editor's Choice - Relationship Between Global Limb Anatomic Staging System (GLASS) and Clinical Outcomes Following Revascularisation for Chronic Limb Threatening Ischaemia in the Bypass Versus Angioplasty in Severe Ischaemia of the Leg (BASIL)-1 Trial.
    Kodama A; Meecham L; Popplewell M; Bate G; Conte MS; Bradbury AW
    Eur J Vasc Endovasc Surg; 2020 Nov; 60(5):687-695. PubMed ID: 32778491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angioplasty versus stenting for infrapopliteal arterial lesions in chronic limb-threatening ischaemia.
    Hsu CC; Kwan GN; Singh D; Rophael JA; Anthony C; van Driel ML
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD009195. PubMed ID: 30536919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Comparison of Clinical Outcomes Following Femoropopliteal Bypass or Plain Balloon Angioplasty with Selective Bare Metal Stenting in the Bypass Versus Angioplasty in Severe Ischaemia of the Limb (BASIL) Trial.
    Meecham L; Bate G; Patel S; Bradbury AW
    Eur J Vasc Endovasc Surg; 2019 Jul; 58(1):52-59. PubMed ID: 30786974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results for primary bypass versus primary angioplasty/stent for lower extremity chronic limb-threatening ischemia.
    Darling JD; McCallum JC; Soden PA; Korepta L; Guzman RJ; Wyers MC; Hamdan AD; Schermerhorn ML
    J Vasc Surg; 2017 Aug; 66(2):466-475. PubMed ID: 28274753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes of bypass-first versus endovascular-first strategy in patients with chronic limb-threatening ischemia due to infrageniculate arterial disease.
    Dayama A; Tsilimparis N; Kolakowski S; Matolo NM; Humphries MD
    J Vasc Surg; 2019 Jan; 69(1):156-163.e1. PubMed ID: 30579443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Femoropopliteal balloon angioplasty vs. bypass surgery for CLI: a propensity score analysis.
    Korhonen M; Biancari F; Söderström M; Arvela E; Halmesmäki K; Albäck A; Lepäntalo M; Venermo M
    Eur J Vasc Endovasc Surg; 2011 Mar; 41(3):378-84. PubMed ID: 21195637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes after first-time lower extremity revascularization for chronic limb-threatening ischemia in insulin-dependent diabetic patients.
    Darling JD; O'Donnell TFX; Deery SE; Norman AV; Vu GH; Guzman RJ; Wyers MC; Hamdan AD; Schermerhorn ML
    J Vasc Surg; 2018 Nov; 68(5):1455-1464.e1. PubMed ID: 30360841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Situ Vein Bypass Is Superior to Endovascular Treatment of Femoropopliteal Lesions in Chronic Limb-Threatening Ischemia.
    Lawaetz M; Fisker L; Lönn L; Sillesen H; Eiberg J
    Ann Vasc Surg; 2020 Aug; 67():437-447. PubMed ID: 32234573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amputation-free survival, limb symptom alleviation, and reintervention rates after open and endovascular revascularization of femoropopliteal lesions in patients with chronic limb-threatening ischemia.
    Perlander A; Jivegård L; Nordanstig J; Svensson M; Österberg K
    J Vasc Surg; 2020 Dec; 72(6):1987-1995. PubMed ID: 32276010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endovascular Therapy Provides Similar Results of Bypass Graft Surgery in the Treatment of Infrainguinal Multilevel Arterial Disease in Patients with Chronic Limb-Threatening Ischemia in All GLASS Stages.
    Casella IB; Sartori CH; Faustino CB; Vieira Mariz MP; Presti C; Puech-Leão P; De Luccia N
    Ann Vasc Surg; 2020 Oct; 68():400-408. PubMed ID: 32339688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient selection and perioperative outcomes of bypass and endovascular intervention as first revascularization strategy for infrainguinal arterial disease.
    Bodewes TCF; Darling JD; Deery SE; O'Donnell TFX; Pothof AB; Shean KE; Moll FL; Schermerhorn ML
    J Vasc Surg; 2018 Jan; 67(1):206-216.e2. PubMed ID: 28844467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Limb Salvage and Amputation-Free Survival After Femoropopliteal Bypass and Femoropopliteal PTA for Critical Ischemia in a Clinical Cohort.
    Altreuther M; Mattsson E
    Vasc Endovascular Surg; 2019 Feb; 53(2):112-117. PubMed ID: 30803415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contemporary (2009-2014) clinical outcomes after femoropopliteal bypass surgery for chronic limb threatening ischemia are inferior to those reported in the UK Bypass versus Angioplasty for Severe Ischaemia of the Leg (BASIL) trial (1999-2004).
    Meecham L; Popplewell M; Bate G; Patel S; Bradbury AW
    J Vasc Surg; 2019 Jun; 69(6):1840-1847. PubMed ID: 30852037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vein bypass first vs. best endovascular treatment first revascularisation strategy for chronic limb-threatening ischaemia due to infra-popliteal disease: the BASIL-2 RCT.
    Moakes CA; Bradbury AW; Abdali Z; Bate GR; Hall J; Jarrett H; Kelly L; Kigozi J; Lockyer S; Meecham L; Patel S; Popplewell M; Slinn G; Deeks JJ;
    Health Technol Assess; 2024 Oct; 28(65):1-72. PubMed ID: 39397484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic review and meta-analysis of revascularization outcomes of infrainguinal chronic limb-threatening ischemia.
    Almasri J; Adusumalli J; Asi N; Lakis S; Alsawas M; Prokop LJ; Bradbury A; Kolh P; Conte MS; Murad MH
    Eur J Vasc Endovasc Surg; 2019 Jul; 58(1S):S110-S119. PubMed ID: 31221539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival prediction in patients with chronic limb-threatening ischemia who undergo infrainguinal revascularization.
    Simons JP; Schanzer A; Flahive JM; Osborne NH; Mills JL; Bradbury AW; Conte MS
    Eur J Vasc Endovasc Surg; 2019 Jul; 58(1S):S120-S134.e3. PubMed ID: 31151867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Revascularisation of Chronic Limb Threatening Ischaemia in Patients with no Pedal Arteries Leads to Lower Midterm Limb Salvage.
    Vacirca A; Faggioli G; Pini A; Pini R; Abualhin M; Sonetto A; Spath P; Gargiulo M
    Eur J Vasc Endovasc Surg; 2023 Jun; 65(6):878-886. PubMed ID: 37028588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease Specific Health Related Quality of Life in Patients With Chronic Limb Threatening Ischaemia Undergoing Revascularisation of Femoropopliteal Lesions.
    Perlander A; Broeren M; Österberg K; Svensson M; Nordanstig J
    Eur J Vasc Endovasc Surg; 2023 Aug; 66(2):245-251. PubMed ID: 37201719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic immunosuppression does not affect revascularization outcomes in patients with chronic limb-threatening ischemia.
    Romary DJ; Darling JD; Patel PB; Dash SP; Schermerhorn ML; Lee AM
    J Vasc Surg; 2024 Jan; 79(1):111-119.e2. PubMed ID: 37717639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.